Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Operating CF Margin

-677.64%

Quarterly · Period ending:

LCTX logo

LCTX Operating CF Margin

Latest reported-677.64%
LCTX Quarterly Operating CF Margin (0.00% → -677.64%)
High-resolution chart · PNG

LCTX operating cf margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Operating CF Margin — Quarterly
Period endingOperating CF Margin
-2,696.3482%
-3,094.8127%
-1,635.4708%
0%
0%
0%
-3,453.0693%
-500%
-233.3333%
-300%
-1,200%
-250%
-1,200%
-240%
-1,000%
0%
-700%
-500%
-600%
0%
0%
0%
-600%
0%
-500%
-600%
-500%
0%
-300%
-400%
-300%
0%
-300%
-300%
-300%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.